The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital
Article in Vaccines (April 2023)
The most recent citing publication is shown below. View this citation on Dimensions.